फ्लुड्रोकॉर्टिसोन के इंटरैक्शन

Use of a LABA, including arformoterol tartrate inhalation solution, without an inhaled corticosteroid is contraindicated in patients with asthma. (आरफॉर्मोटेरोल लेबल, निषेध (कॉन्ट्राइंडिकेशन))

If differentiation syndrome is suspected, immediately initiate high-dose corticosteroids and hemodynamic monitoring until resolution. (आर्सेनिक ट्राइऑक्साइड लेबल, बॉक्स्ड चेतावनी)

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

Withhold INLYTA and avelumab or pembrolizumab, initiate corticosteroid therapy as needed, and/or permanently discontinue the combination for severe or life-threatening hepatotoxicity. (एक्सिटिनिब लेबल, चेतावनियां और सावधानियां)

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

Coadministration of fluticasone propionate and REYATAZ with ritonavir is not recommended unless the potential benefit to the patient outweighs the risk of systemic corticosteroid side effects [see Warnings and Precautions (5.1) ] . (एटाज़ानाविर लेबल, दवाओं के इंटरैक्शन)

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

…Antihistamines Thyroid hormones Diuretics Cardiac glycosides, such as digitalis glycosides Quinidine Drugs potentiating hypokalemic effects of epinephrine • Potassium depleting diuretics • Corticosteroids • Theophylline Epinephrine should not be used to counteract circulatory collapse or hypotension caused by phenothiazines, as a reversal of the pressor effects of epinephrine… (एड्रेनालिन लेबल, दवाओं के इंटरैक्शन)

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

At the primary analysis, increased incidences of fractures (28.6% vs 11.4%) and deaths (38.5% vs 35.5%) have been observed in patients who received abiraterone acetate plus a corticosteroid in combination with radium Ra 223 dichloride compared to patients who received placebo in combination with abiraterone acetate plus a corticosteroid. (एबिराटेरोन लेबल, चेतावनियां और सावधानियां)

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

…(5.7) , Drug Interactions (7) , and Clinical Pharmacology (12.3) ]: Anticonvulsants: carbamazepine, oxcarbazepine, phenobarbital, phenytoin Antimycobacterials: rifampin, rifapentine Glucocorticoid (systemic): dexamethasone (more than a single-dose) Herbal Products: St John's wort ( Hypericum perforatum ) Proton Pump Inhibitors: e.g., dexlansoprazole, esomeprazole,… (एमट्रिसिटाबिन, रिल्पिविरिन और टेनोफोविर लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

Fluticasone: Coadministration of fluticasone propionate and ketoconazole is not recommended unless the potential benefit to the patient outweighs the risk of systemic corticosteroid side effects. (कीटोकोनाज़ोल लेबल, दवाओं के इंटरैक्शन)

Triple combination of candesartan cilexetil with an ACE-inhibitor and a mineralocorticoid receptor antagonist is generally not recommended. (कैंडेसार्टन लेबल, दवाओं के इंटरैक्शन)

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

At first signs or symptoms of this syndrome, immediately initiate high-dose corticosteroid therapy and hemodynamic monitoring until resolution of signs and symptoms. (ट्रेटिनोइन लेबल, बॉक्स्ड चेतावनी)

Two of the four cases were life-threatening and resolved without treatment or with medication (corticosteroids). (ट्रैंडोलाप्रिल लेबल, चेतावनियां)

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

Severe hypersensitivity reactions characterized by generalized rash/erythema, hypotension and/or bronchospasm, or fatal anaphylaxis, have been reported in patients premedicated with 3 days of corticosteroids. (डोसेटैक्सेल लेबल, चेतावनियां और सावधानियां)

…2 , Drug Interactions (7.3) ] ) • Immunosuppressants: voclosporin • Microsomal triglyceride transfer protein inhibitor: lomitapide • Migraine medications: eletriptan, ubrogepant • Mineralocorticoid receptor antagonists: finerenone • Non-opioid analgesic (selective blocker of Na v 1.8 sodium channels): suzetrigine • Opioid antagonists: naloxegol • PDE5 inhibitor:… (निर्माट्रेल्विर और रिटोनाविर लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

Use of a LABA, including formoterol fumarate inhalation solution, without an inhaled corticosteroid is contraindicated in patients with asthma [see Warnings and Precautions (5.1) ]. (फॉर्मोटेरोल लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Coadministration of fluticasone and fosamprenavir calcium/ritonavir is not recommended unless the potential benefit to the patient outweighs the risk of systemic corticosteroid side effects. (फोसएम्प्रेनाविर लेबल, दवाओं के इंटरैक्शन)

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

If shock, severe trauma or infection occurs or develops, temporarily discontinue LYSODREN and administer exogenous steroids. (माइटोटेन लेबल, बॉक्स्ड चेतावनी)

WARNING: TERMINATION OF PREGNANCY Mifepristone is a potent antagonist of progesterone and cortisol via the progesterone and glucocorticoid (GR-II) receptors, respectively. (मिफेप्रिस्टोन लेबल, बॉक्स्ड चेतावनी)

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

None of the cases were considered life-threatening and all resolved either without treatment or with medication (antihistamines or glucocorticoids). (मोएक्सिप्रिल लेबल, चेतावनियां)

• use of a long-acting beta 2 -adrenergic agonist (LABA), including vilanterol, one of the active ingredients in Umeclidinium and Vilanterol ELLIPTA, without an inhaled corticosteroid (ICS), in patients with asthma [see Warnings and Precautions ( 5.1 )] . (यूमेक्लिडिनियम और विलैंटेरोल लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

Antimycobacterials Rifampin Rifapentine Glucocorticoid (systemic) Dexamethasone (more than a single-dose treatment) Herbal Products St. (रिल्पिविरिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

Moreover, cholesterol and other products of the cholesterol biosynthesis pathway are essential components for fetal development, including synthesis of steroids and cell membranes. (लोवास्टेटिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

Chicken pox and measles, for example, can have a more serious or even fatal course in children on immunosuppressant corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

WARNING: ASTHMA-RELATED DEATH Long-acting beta 2 -adrenergic agonists (LABA), such as salmeterol, the active ingredient in SEREVENT DISKUS, as monotherapy (without inhaled corticosteroids [ICS]) increase the risk of asthma-related death. (सैल्मेटेरोल लेबल, बॉक्स्ड चेतावनी)

Intervention: Carefully adjust glucocorticoid dosing in pediatric patients receiving glucocorticoid treatments to avoid both hypoadrenalism and an inhibitory effect on growth. (सोमाट्रोपिन लेबल, दवाओं के इंटरैक्शन)

Patients receiving concomitant corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs) or anti-angiogenic agents, or patients with increasing age or who have an underlying history of gastrointestinal ulceration, underlying diverticular disease or bowel metastases may be at increased risk of perforation. (अफाटिनिब लेबल, चेतावनियां और सावधानियां)

Other factors that increase the risk of GI bleeding in patients treated with NSAIDs include longer duration of NSAID therapy; concomitant use of oral corticosteroids, aspirin, anticoagulants, or selective serotonin reuptake inhibitors (SSRIs); smoking; use of alcohol; older age; and poor general health status. (आइबुप्रोफेन लेबल, चेतावनियां और सावधानियां)

Other factors that increase the risk of GI bleeding in patients treated with NSAIDs include longer duration of NSAID therapy; concomitant use of oral corticosteroids, aspirin, anticoagulants, or selective serotonin reuptake inhibitors (SSRIs); smoking; use of alcohol; older age; and poor general health status. (आइबुप्रोफेन और फैमोटिडीन लेबल, चेतावनियां और सावधानियां)

Oral hydration, recumbency, intravenous normal saline, and/or parenteral corticosteroids have been used to treat postural hypotension. (आइवरमेक्टिन लेबल, चेतावनियां)

Although other risk factors were present in some cases (such as corticosteroid use and/or exposure to radiation), a possible risk attributable to KALYDECO cannot be excluded. (आइवाकैफ्टर लेबल, चेतावनियां और सावधानियां)

Oral anticoagulants — decreased prothrombin time response. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Other factors that increase the risk of GI bleeding in patients treated with NSAIDs include longer duration of NSAID therapy; concomitant use of oral corticosteroids, aspirin, anticoagulants, or selective serotonin reuptake inhibitors (SSRIs); smoking; use of alcohol; older age; and poor general health status. (इंडोमेथासिन लेबल, चेतावनियां और सावधानियां)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

…osteonecrosis of the jaw include invasive dental procedures (e.g., tooth extraction, dental implants, boney surgery), diagnosis of cancer, concomitant therapies (e.g., chemotherapy, corticosteroids, angiogenesis inhibitors), poor oral hygiene, and co-morbid disorders (e.g., periodontal and/or other pre-existing dental disease, anemia, coagulopathy, infection, ill-fitting… (इबैंड्रोनेट लेबल, चेतावनियां और सावधानियां)

If either is abnormal, consider prophylactic use of systemic steroids (1-2 mg/kg) for one to two weeks concomitantly with Gleevec at the initiation of therapy. (इमैटिनिब लेबल, चेतावनियां और सावधानियां)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Sympathomimetics, Methylxanthines, Steroids In clinical studies, concurrent administration of aclidinium bromide and other drugs commonly used in the treatment of COPD including sympathomimetics (short-acting beta 2 agonists), methylxanthines, and oral and inhaled steroids showed no increases in adverse drug reactions. (एक्लिडिनियम लेबल, दवाओं के इंटरैक्शन)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Other factors that increase the risk for GI bleeding in patients treated with NSAIDs include concomitant use of oral corticosteroids or anticoagulants, longer duration of NSAID therapy, smoking, use of alcohol, older age, and poor general health status. (एटोडोलैक लेबल, चेतावनियां)

Estrogen —increased levels of corticosteroid-binding globulin thereby increasing the bound (inactive) fraction; this effect is at least balanced by decreased metabolism of corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Corticosteroid : dexamethasone (systemic) ↓ etravirine Systemic dexamethasone induces CYP3A and can decrease etravirine plasma concentrations. (एट्राविरिन लेबल, दवाओं के इंटरैक्शन)

Oral anticoagulants — decreased prothrombin time response. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Estrogen —increased levels of corticosteroid-binding globulin thereby increasing the bound (inactive) fraction; this effect is at least balanced by decreased metabolism of corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Oral anticoagulants — decreased prothrombin time response. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Oral anticoagulants — decreased prothrombin time response. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Patients receiving concomitant anti-angiogenic agents, corticosteroids, NSAIDs, or taxane-based chemotherapy, or who have prior history of peptic ulceration or diverticular disease may be at increased risk of perforation [see Adverse Reactions (6.1 , 6.2) ]. (एर्लोटिनिब लेबल, चेतावनियां और सावधानियां)

Patients who experience these effects, even without respiratory distress, require prolonged observation and appropriate monitoring measures since treatment with antihistamines and corticosteroids may not be sufficient to prevent respiratory involvement. (एलिस्किरेन लेबल, चेतावनियां और सावधानियां)

…osteonecrosis of the jaw include invasive dental procedures (e.g., tooth extraction, dental implants, boney surgery), diagnosis of cancer, concomitant therapies (e.g., chemotherapy, corticosteroids, angiogenesis inhibitors), poor oral hygiene, and co-morbid disorders (e.g., periodontal and/or other pre-existing dental disease, anemia, coagulopathy, infection, ill-fitting… (एलेंड्रोनेट लेबल, चेतावनियां और सावधानियां)

Although other risk factors were present in some cases (such as corticosteroid use, exposure to radiation), a possible risk attributable to treatment with ivacaftor cannot be excluded. (एलेक्साकैफ्टर, टेज़ाकैफ्टर और आइवाकैफ्टर लेबल, चेतावनियां और सावधानियां)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

If a SCAR is not confirmed, VIJOICE may require dose modifications, topical or systemic corticosteroids, or oral antihistamine treatment as described in Table 4 [see Dosage and Administration (2.5)] . (एल्पेलिसिब लेबल, चेतावनियां और सावधानियां)

Risk of Neurologic Symptoms: Neurocysticercosis patients may experience cerebral hypertensive episodes, seizures or focal neurologic deficits after initiation of therapy; begin appropriate steroid and anticonvulsant therapy. (एल्बेंडाज़ोल लेबल, चेतावनियां और सावधानियां)

Corticosteroids: e.g., betamethasone budesonide ciclesonide dexamethasone fluticasone methylprednisolone mometasone prednisone triamcinolone ↓ elvitegravir ↓ cobicistat ↑ corticosteroids Coadministration with oral dexamethasone or other systemic corticosteroids that induce CYP3A may result in loss of therapeutic effect and development of resistance to elvitegravir. (एल्विटेग्राविर, कोबिसिस्टैट, एमट्रिसिटाबिन और टेनोफोविर लेबल, दवाओं के इंटरैक्शन)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Anabolic steroids (particularly C-17 alkylated androgens such as oxymetholone, methandrostenolone, norethandrolone, and similar compounds)—enhanced tendency toward edema. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Estrogen —increased levels of corticosteroid-binding globulin thereby increasing the bound (inactive) fraction; this effect is at least balanced by decreased metabolism of corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Estrogen —increased levels of corticosteroid-binding globulin thereby increasing the bound (inactive) fraction; this effect is at least balanced by decreased metabolism of corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Estrogen —increased levels of corticosteroid-binding globulin thereby increasing the bound (inactive) fraction; this effect is at least balanced by decreased metabolism of corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Aspirin — increased ulcerogenic effect; decreased pharmacologic effect of aspirin. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Aspirin — increased ulcerogenic effect; decreased pharmacologic effect of aspirin. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Other factors that increase the risk of GI bleeding in patients treated with NSAIDs include longer duration of NSAID therapy; concomitant use of oral corticosteroids, antiplatelet drugs (such as aspirin), anticoagulants, or selective serotonin reuptake inhibitors (SSRIs); smoking; use of alcohol; older age; and poor general health status. (ऑक्साप्रोज़िन लेबल, चेतावनियां और सावधानियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (ऑक्सीकोडोन लेबल, चेतावनियां और सावधानियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (ऑक्सीकोडोन और पैरासिटामोल लेबल, चेतावनियां और सावधानियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (ऑक्सीमॉर्फोन लेबल, चेतावनियां और सावधानियां)

Aspirin — increased ulcerogenic effect; decreased pharmacologic effect of aspirin. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

The risk of developing fluoroquinolone-associated tendinitis and tendon rupture is increased in patients over 60 years of age, in those taking corticosteroid drugs, and in patients with kidney, heart or lung transplants. (ओफ्लॉक्सासिन लेबल, चेतावनियां)

Corticosteroid Reduction: Do not abruptly discontinue corticosteroids upon initiation of OMLYCLO therapy. (ओमालिज़ुमैब लेबल, चेतावनियां और सावधानियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (ओलिसेरिडिन लेबल, चेतावनियां और सावधानियां)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Estrogen —increased levels of corticosteroid-binding globulin thereby increasing the bound (inactive) fraction; this effect is at least balanced by decreased metabolism of corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Estrogen —increased levels of corticosteroid-binding globulin thereby increasing the bound (inactive) fraction; this effect is at least balanced by decreased metabolism of corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

PRECAUTIONS General Ketoprofen Capsules, USP cannot be expected to substitute for corticosteroids or to treat corticosteroid insufficiency. (कीटोप्रोफेन लेबल, चेतावनियां और सावधानियां)

In addition to past history of ulcer disease, other factors that increase the risk for GI bleeding in patients treated with NSAIDs include concomitant use of oral corticosteroids, or anticoagulants, longer duration of NSAID therapy, smoking, use of alcohol, older age, and poor general health status. (कीटोरोलैक लेबल, चेतावनियां और सावधानियां)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Plasma cholinesterase activity may be decreased by chronic administration of certain monoamine oxidase inhibitors, oral contraceptives, glucocorticoids, antimyasthenics (neostigmine), cyclophosphamide, and possibly thiotepa. (कोकेन लेबल, दवाओं के इंटरैक्शन)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (कोडीन लेबल, चेतावनियां और सावधानियां)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Corticosteroids, valproic acid, or haloperidol : May increase plasma ammonia level; monitor ammonia levels closely. (ग्लिसरॉल फिनाइलब्यूटिरेट लेबल, दवाओं के इंटरैक्शन)

Prior to the first BIZENGRI infusion, premedicate with a corticosteroid, an H1 antihistamine and acetaminophen to reduce the risk of IRRs [see Dosage and Administration (2.4) ]. (ज़ेनोक्यूटुज़ुमैब लेबल, चेतावनियां और सावधानियां)

A dental examination with appropriate preventive dentistry should be considered prior to treatment with bisphosphonates in patients with a history of concomitant risk factors (e.g., cancer, chemotherapy, angiogenesis inhibitors, radiotherapy, corticosteroids, poor oral hygiene, preexisting dental disease or infection, anemia, coagulopathy). (ज़ोलेड्रोनिक एसिड लेबल, चेतावनियां और सावधानियां)

If the patient needs more doses of terbutaline sulfate tablets than usual, this may be a marker of destabilization of asthma and requires reevaluation of the patient and the treatment regimen, giving special consideration to the possible need for anti-inflammatory treatment, e.g., corticosteroids. (टरब्यूटालिन लेबल, चेतावनियां)

Concomitant Respiratory Medications SPIRIVA RESPIMAT has been used concomitantly with short-acting and long-acting sympathomimetic (beta-agonists) bronchodilators, methylxanthines, oral and inhaled steroids, antihistamines, mucolytics, leukotriene modifiers, cromones, and anti-IgE treatment without increases in adverse reactions. (टियोट्रोपियम लेबल, दवाओं के इंटरैक्शन)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (टेपेंटाडोल लेबल, चेतावनियां और सावधानियां)

Pneumocystis Pneumonia (PCP) : Closely monitor all patients, particularly those receiving steroids, for the development of lymphopenia and PCP. (टेमोज़ोलोमाइड लेबल, चेतावनियां और सावधानियां)

If ILD is suspected, discontinue TORISEL, and consider use of corticosteroids and/or antibiotics. (टेम्सिरोलिमस लेबल, चेतावनियां और सावधानियां)

Risk factors for development of calciphylaxis include underlying auto-immune disease, kidney failure, and concomitant warfarin or systemic corticosteroid use. (टेरिपैराटाइड लेबल, चेतावनियां और सावधानियां)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Glucocorticoids : Patients receiving glucocorticoid replacement for previously diagnosed hypoadrenalism may require an increase in maintenance or stress doses following initiation of EGRIFTA SV. (टेसामोरेलिन लेबल, दवाओं के इंटरैक्शन)

Anabolic steroids (particularly C-17 alkylated androgens such as oxymetholone, methandrostenolone, norethandrolone, and similar compounds)—enhanced tendency toward edema. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Other factors that increase the risk for GI bleeding in patients treated with NSAIDs include concomitant use of oral corticosteroids or anticoagulants, longer duration of NSAID therapy, smoking, use of alcohol, older age, and poor general health status. (टोल्मेटिन लेबल, चेतावनियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (ट्रामाडोल लेबल, चेतावनियां और सावधानियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (ट्रामाडोल और पैरासिटामोल लेबल, चेतावनियां और सावधानियां)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Interrupt TRAZIMERA infusion in all patients experiencing dyspnea, clinically significant hypotension, and intervention of medical therapy administered (which may include epinephrine, corticosteroids, diphenhydramine, bronchodilators, and oxygen). (ट्रैस्टुज़ुमैब लेबल, चेतावनियां और सावधानियां)

Other factors that increase the risk of GI bleeding in patients treated with NSAIDs include longer duration of NSAID therapy; concomitant use of oral corticosteroids, aspirin, anticoagulants, or selective serotonin reuptake inhibitors (SSRIs); smoking; use of alcohol; older age; and poor general health status. (डाइक्लोफेनाक लेबल, चेतावनियां और सावधानियां)

Other factors that increase the risk of GI bleeding in patients treated with NSAIDs include longer duration of NSAID therapy; concomitant use of oral corticosteroids, antiplatelet drugs (such as aspirin), anticoagulants, or selective serotonin reuptake inhibitors (SSRIs); smoking; use of alcohol; older age; and poor general health status. (डाइक्लोफेनाक और मिसोप्रोस्टोल लेबल, चेतावनियां और सावधानियां)

Rarely salicylate toxicity may occur in patients who discontinue steroids after concurrent high-dose aspirin therapy. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Anticholinergic drugs in the presence of increased intraocular pressure may be hazardous when taken concurrently with agents such as corticosteroids. (डाइसाइक्लोमिन लेबल, दवाओं के इंटरैक्शन)

Corticosteroids: dexamethasone (systemic) ↓ darunavir Co-administration of PREZISTA/ritonavir with systemic dexamethasone or other systemic corticosteroids that induce CYP3A may result in loss of therapeutic effect and development of resistance to darunavir. (डारुनाविर लेबल, दवाओं के इंटरैक्शन)

Corticosteroids: dexamethasone (systemic) Corticosteroids primarily metabolized by CYP3A: e.g. betamethasone budesonide ciclesonide fluticasone methylprednisolone mometasone triamcinolone ↓ darunavir ↓ cobicistat ↑ corticosteroids Co-administration with systemic dexamethasone or other systemic corticosteroids that induce CYP3A may result in loss of therapeutic… (डारुनाविर और कोबिसिस्टैट लेबल, दवाओं के इंटरैक्शन)

Digitalis glycosides — enhanced possibility of arrhythmias or digitalis toxicity associated with hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Eosinophilic Conditions: Be alert to vasculitic rash, worsening pulmonary symptoms, cardiac complications, kidney injury and/or neuropathy, especially upon reduction of oral corticosteroids. (डुपिलुमैब लेबल, चेतावनियां और सावधानियां)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Other risk factors for the development of ONJ include immunosuppressive therapy, treatment with angiogenesis inhibitors, systemic corticosteroids, diabetes, and gingival infections. (डेनोसुमैब लेबल, चेतावनियां और सावधानियां)

The risk of GI hemorrhage may be increased when administering Exjade in combination with drugs that have ulcerogenic or hemorrhagic potential, such as nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, oral bisphosphonates, or anticoagulants. (डेफेरासिरोक्स लेबल, चेतावनियां और सावधानियां)

Estrogen —increased levels of corticosteroid-binding globulin thereby increasing the bound (inactive) fraction; this effect is at least balanced by decreased metabolism of corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Anabolic steroids (particularly C-17 alkylated androgens such as oxymetholone, methandrostenolone, norethandrolone, and similar compounds)—enhanced tendency toward edema. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Eosinophilic pneumonia: Discontinue Daptomycin for Injection and consider treatment with systemic steroids. (डैप्टोमाइसिन लेबल, चेतावनियां और सावधानियां)

Oral anticoagulants — decreased prothrombin time response. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Monitor serum potassium levels; use potassium supplements if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Estrogen —increased levels of corticosteroid-binding globulin thereby increasing the bound (inactive) fraction; this effect is at least balanced by decreased metabolism of corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Dosage Increases: Increases in the dose of theophylline should not be made in response to an acute exacerbation of symptoms of chronic lung disease since theophylline provides little added benefit to inhaled beta2 -selective agonists and systemically administered corticosteroids in this circumstance and increases the risk of adverse effects. (थियोफाइलिन लेबल, चेतावनियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (नालबुफिन लेबल, चेतावनियां)

…hypoglycemia concomitant administration of medications that may lower the seizure threshold, including other bupropion products, antipsychotics, tricyclic antidepressants, theophylline, systemic steroids Recommendations for Reducing the Risk of Seizure: Clinical experience with bupropion suggests that the risk of seizure may be minimized by adhering to the recommended… (नाल्ट्रेक्सोन और ब्यूप्रोपियॉन लेबल, चेतावनियां और सावधानियां)

Use OFEV with caution when treating patients with recent abdominal surgery, previous history of diverticular disease or receiving concomitant corticosteroids or NSAIDs. (निंटेडानिब लेबल, चेतावनियां और सावधानियां)

Monitor serum potassium levels; use potassium supplements if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Other factors that increase the risk of GI bleeding in patients treated with NSAIDs include longer duration of NSAID therapy; concomitant use of oral corticosteroids, aspirin, anticoagulants, or selective serotonin reuptake inhibitors (SSRIs); smoking; use of alcohol; older age; and poor general health status. (नेप्रोक्सेन लेबल, चेतावनियां और सावधानियां)

Other factors that increase the risk for GI bleeding in patients treated with NSAIDs include longer duration of NSAID therapy; concomitant use of oral corticosteroids, aspirin, anticoagulants, or selective serotonin reuptake inhibitors (SSRIs); smoking; use of alcohol; older age; and poor general health status. (नेप्रोक्सेन और एसोमेप्राज़ोल लेबल, चेतावनियां और सावधानियां)

Other factors that increase the risk for GI bleeding in patients treated with NSAIDs include concomitant use of oral corticosteroids or anticoagulants, longer duration of NSAID therapy, smoking, use of alcohol, older age, and poor general health status. (नैबुमेटोन लेबल, चेतावनियां)

Estrogen —increased levels of corticosteroid-binding globulin thereby increasing the bound (inactive) fraction; this effect is at least balanced by decreased metabolism of corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Estrogen —increased levels of corticosteroid-binding globulin thereby increasing the bound (inactive) fraction; this effect is at least balanced by decreased metabolism of corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Estrogen —increased levels of corticosteroid-binding globulin thereby increasing the bound (inactive) fraction; this effect is at least balanced by decreased metabolism of corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Estrogen —increased levels of corticosteroid-binding globulin thereby increasing the bound (inactive) fraction; this effect is at least balanced by decreased metabolism of corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Other factors that increase the risk of GI bleeding in patients treated with NSAIDs include longer duration of NSAID therapy; concomitant use of oral corticosteroids, antiplatelet drugs (such as aspirin), anticoagulants, or selective serotonin reuptake inhibitors (SSRIs); smoking; use of alcohol; older age; and poor general health status. (पाइरोक्सिकैम लेबल, चेतावनियां और सावधानियां)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (पेंटाज़ोसिन और नालोक्सोन लेबल, चेतावनियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (पेथिडीन लेबल, चेतावनियां और सावधानियां)

Treatment has consisted of high doses of corticosteroids alone or, in some cases, concomitantly with an immunosuppressant. (पेनिसिलामिन लेबल, चेतावनियां)

Many of these patients were also receiving chemotherapy and corticosteroids, which may be risk factors for ONJ. (पैमिड्रोनेट लेबल, चेतावनियां और सावधानियां)

Other factors that increase the risk of GI bleeding in patients treated with NSAIDs include longer duration of NSAID therapy, concomitant use of oral corticosteroids, aspirin, anticoagulants, or selective serotonin reuptake inhibitors (SSRIs); smoking; use of alcohol; older age; and poor general health status. (पैरासिटामोल और आइबुप्रोफेन लेबल, चेतावनियां और सावधानियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (पैरासिटामोल और कोडीन लेबल, चेतावनियां)

If adrenal insufficiency is suspected, it should be confirmed and treated per standard of care with exogenous glucocorticoids at replacement doses . (पैसिरियोटाइड लेबल, चेतावनियां और सावधानियां)

Monitor serum potassium levels; use potassium supplements if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Monitor serum potassium levels; use potassium supplements if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Monitor serum potassium levels; use potassium supplements if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Barbiturates, phenytoin, or rifampin —increased metabolic clearance of fludrocortisone acetate because of the induction of hepatic enzymes. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

The following appear to be major risk factors for the development of these events: decreased oxygen delivery to tissues; serious neurological injury and/or sepsis; high dosages of one or more of the following pharmacological agents: vasoconstrictors, steroids, inotropes and/or prolonged, high-dose infusions of propofol (> 5 mg/kg/hour for > 48 hours). (प्रोपोफोल लेबल, चेतावनियां और सावधानियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (प्रोमेथाज़िन और कोडीन लेबल, चेतावनियां और सावधानियां)

Agonistic Effects (increase in BIORPHEN blood pressure effect) can occur with monoamine oxidase inhibitors (MAOI), oxytocin and oxytocic drugs, tricyclic antidepressants, angiotensin and aldosterone, atropine, steroids, norepinephrine transporter inhibitors, ergot alkaloids. (फिनाइलएफ्रिन लेबल, दवाओं के इंटरैक्शन)

Estrogen —increased levels of corticosteroid-binding globulin thereby increasing the bound (inactive) fraction; this effect is at least balanced by decreased metabolism of corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (फेंटानिल लेबल, चेतावनियां और सावधानियां)

Barbiturates, phenytoin, or rifampin —increased metabolic clearance of fludrocortisone acetate because of the induction of hepatic enzymes. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Other factors that increase the risk for GI bleeding in patients treated with NSAIDs include longer duration of NSAID therapy; concomitant use of oral corticosteroids, aspirin, anticoagulants, or selective serotonin reuptake inhibitors (SSRIs); smoking; use of alcohol; older age; and poor general health status. (फेनोप्रोफेन लेबल, चेतावनियां और सावधानियां)

Barbiturates, phenytoin, or rifampin —increased metabolic clearance of fludrocortisone acetate because of the induction of hepatic enzymes. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Barbiturates, phenytoin, or rifampin —increased metabolic clearance of fludrocortisone acetate because of the induction of hepatic enzymes. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Other Corticosteroids, doxycycline, estrogens, furosemide, oral contraceptives, paroxetine, quinidine, rifampin, sertraline, theophylline, and vitamin D Drugs whose level is decreased by phenytoin Anticoagulants Apixaban, dabigatran, edoxaban, rivaroxaban Antiepileptic drugs The effect of phenytoin on phenobarbital, valproic acid and sodium valproate serum levels… (फॉस्फेनिटोइन लेबल, दवाओं के इंटरैक्शन)

Oral anticoagulants — decreased prothrombin time response. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Other factors that increase the risk of GI bleeding in patients treated with NSAIDs include longer duration of NSAID therapy; concomitant use of oral corticosteroids, aspirin, anticoagulants, or selective serotonin reuptake inhibitors (SSRIs); smoking, use of alcohol, older age, and poor general health status. (फ्लर्बिप्रोफेन लेबल, चेतावनियां और सावधानियां)

Use of more than one corticosteroid-containing product at the same time may increase the total systemic absorption of topical corticosteroids. (फ्लुओसिनोनाइड लेबल, चेतावनियां और सावधानियां)

Anabolic steroids (particularly C-17 alkylated androgens such as oxymetholone, methandrostenolone, norethandrolone, and similar compounds)—enhanced tendency toward edema. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Although Fluticasone Propionate DISKUS may control asthma symptoms during these episodes, in recommended doses it supplies less than normal physiological amounts of glucocorticoid systemically and does NOT provide the mineralocorticoid activity that is necessary for coping with these emergencies. (फ्लुटिकासोन लेबल, चेतावनियां और सावधानियां)

In this situation, the patient requires immediate reevaluation with reassessment of the treatment regimen, giving special consideration to the possible need for replacing the current strength of Fluticasone Propionate/Salmeterol MDPI with a higher strength, adding additional inhaled corticosteroid, or initiating systemic corticosteroids. (फ्लुटिकासोन और सैल्मेटेरोल लेबल, चेतावनियां और सावधानियां)

Pregnancy As with other corticosteroids, flunisolide has been shown to be teratogenic and fetotoxic in rabbits and rats at oral doses of 40 and 200 mcg/kg/day, respectively (approximately 2 and 4 times, respectively, the maximum recommended daily intranasal dose in adults on a mg/m 2 basis). (फ्लुनिसोलाइड लेबल, सावधानियां)

Anabolic steroids (particularly C-17 alkylated androgens such as oxymetholone, methandrostenolone, norethandrolone, and similar compounds)—enhanced tendency toward edema. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Rarely salicylate toxicity may occur in patients who discontinue steroids after concurrent high-dose aspirin therapy. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Corticosteroids (systemic): cortisone/hydrocortisone dexamethasone ↑ corticosteroids (systemic) ↓ lenacapavir (dexamethasone) Concomitant administration with systemic corticosteroids whose exposures are significantly increased by CYP3A inhibitors can increase the risk for Cushing's syndrome and adrenal suppression. (बिक्टेग्राविर, एमट्रिसिटाबिन और टेनोफोविर एलाफेनामाइड लेबल, दवाओं के इंटरैक्शन)

Oral anticoagulants — decreased prothrombin time response. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Rarely salicylate toxicity may occur in patients who discontinue steroids after concurrent high-dose aspirin therapy. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Although PULMICORT FLEXHALER may provide control of asthma symptoms during these episodes, in recommended doses it supplies less than normal physiological amounts of glucocorticoid systemically and does NOT provide the mineralocorticoid activity that is necessary for coping with these emergencies. (बुडेसोनाइड लेबल, चेतावनियां और सावधानियां)

In this situation, the patient requires immediate re-evaluation with reassessment of the treatment regimen, giving special consideration to the possible need for replacing the current strength of budesonide and formoterol fumarate dihydrate with a higher strength, adding additional inhaled corticosteroid, or initiating systemic corticosteroids. (बुडेसोनाइड और फॉर्मोटेरोल लेबल, चेतावनियां और सावधानियां)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Consider measures to prevent severe reactions, including antihistamines, antipyretics and corticosteroids in subsequent cycles in patients who have experienced Grade 1 or 2 infusion reactions. (बेंडामुस्टिन लेबल, चेतावनियां और सावधानियां)

Although QVAR REDIHALER may provide control of asthmatic symptoms during these episodes, in recommended doses it supplies less than normal physiological amounts of glucocorticoid systemically and does NOT provide the mineralocorticoid that is necessary for coping with these emergencies. (बेक्लोमेथासोन लेबल, चेतावनियां और सावधानियां)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

• Reduction in Corticosteroid Dosage: Do not discontinue systemic or inhaled corticosteroids abruptly upon initiation of therapy with FASENRA. (बेनरालिज़ुमैब लेबल, चेतावनियां और सावधानियां)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (बेलाडोना और ओपियम लेबल, चेतावनियां और सावधानियां)

Management of orthostatic/postural hypotension may include adjustment of antihypertensive medications, hydration, and administration of mineralocorticoids and/or sympathomimetics. (बोर्टेज़ोमिब लेबल, चेतावनियां और सावधानियां)

Barbiturates, phenytoin, or rifampin —increased metabolic clearance of fludrocortisone acetate because of the induction of hepatic enzymes. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Aspirin — increased ulcerogenic effect; decreased pharmacologic effect of aspirin. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Aspirin — increased ulcerogenic effect; decreased pharmacologic effect of aspirin. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Barbiturates, phenytoin, or rifampin —increased metabolic clearance of fludrocortisone acetate because of the induction of hepatic enzymes. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Barbiturates, phenytoin, or rifampin —increased metabolic clearance of fludrocortisone acetate because of the induction of hepatic enzymes. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (ब्यूटॉर्फेनॉल लेबल, चेतावनियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (ब्यूप्रेनॉर्फिन लेबल, चेतावनियां और सावधानियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (ब्यूप्रेनॉर्फिन और नालोक्सोन लेबल, चेतावनियां और सावधानियां)

…risk of seizure: concomitant use of other medications that lower the seizure threshold (e.g., other bupropion products, antipsychotics, tricyclic antidepressants, theophylline, and systemic corticosteroids), metabolic disorders (e.g., hypoglycemia, hyponatremia, severe hepatic impairment, and hypoxia), or use of illicit drugs (e.g., cocaine) or abuse or misuse… (ब्यूप्रोपियॉन लेबल, चेतावनियां और सावधानियां)

In patients who experience mild or moderate IRRs, consider premedications, including antihistamines, corticosteroids, and antipyretics. (मार्गेटुक्सिमैब लेबल, चेतावनियां और सावधानियां)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

The potential for supine hypertension should be carefully monitored in these patients and may be minimized by either reducing the dose of fludrocortisone acetate or decreasing the salt intake prior to initiation of treatment with midodrine hydrochloride. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

Anabolic steroids (particularly C-17 alkylated androgens such as oxymetholone, methandrostenolone, norethandrolone, and similar compounds)—enhanced tendency toward edema. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

If not, corticosteroids may be given and other causes of anemia should be considered. (मिथाइलडोपा लेबल, चेतावनियां)

Laboratory evaluation for adrenal insufficiency and consideration of replacement or stress doses of a rapidly acting glucocorticoid are strongly recommended in such patients. (मेजेस्ट्रोल लेबल, चेतावनियां और सावधानियां)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

This can be corrected by giving appropriate doses of corticosteroids. (मेटाइरापोन लेबल, चेतावनियां और सावधानियां)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

MPA Injectable Suspension, USP can pose an additional risk in patients with risk factors for osteoporosis (e.g., metabolic bone disease, chronic alcohol and/or tobacco use, anorexia nervosa, strong family history of osteoporosis or chronic use of drugs that can reduce bone mass such as anticonvulsants or corticosteroids). (मेड्रोक्सीप्रोजेस्टेरोन लेबल, चेतावनियां और सावधानियां)

Drug Interactions Methazolamide should be used with caution in patients on steroid therapy because of the potential for developing hypokalemia. (मेथाज़ोलामाइड लेबल, दवाओं के इंटरैक्शन)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (मेथाडोन लेबल, चेतावनियां और सावधानियां)

Barbiturates, phenytoin, or rifampin —increased metabolic clearance of fludrocortisone acetate because of the induction of hepatic enzymes. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Rarely salicylate toxicity may occur in patients who discontinue steroids after concurrent high-dose aspirin therapy. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Decrease corticosteroids gradually, if appropriate. (मेपोलिज़ुमैब लेबल, चेतावनियां और सावधानियां)

Other factors that increase the risk for GI bleeding in patients treated with NSAIDs include longer duration of NSAID therapy, concomitant use of oral corticosteroids, anti-platelet drugs (such as aspirin), anticoagulants, or selective serotonin reuptake inhibitors (SSRIs), smoking, use of alcohol, older age, and poor general health status. (मेफेनामिक एसिड लेबल, चेतावनियां और सावधानियां)

Other factors that increase the risk of GI bleeding in patients treated with NSAIDs include longer duration of NSAID therapy; concomitant use of oral corticosteroids, aspirin, anticoagulants, or selective serotonin reuptake inhibitors (SSRIs); smoking; use of alcohol; older age; and poor general health status. (मेलोक्सिकैम लेबल, चेतावनियां और सावधानियां)

Rarely salicylate toxicity may occur in patients who discontinue steroids after concurrent high-dose aspirin therapy. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

The risk of developing fluoroquinolone-associated tendinitis and tendon rupture is increased in patients over 60 years of age, in patients taking corticosteroid drugs, and in patients with kidney, heart or lung transplants. (मॉक्सीफ्लॉक्सासिन लेबल, चेतावनियां और सावधानियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (मॉर्फिन लेबल, चेतावनियां और सावधानियां)

Inhaled corticosteroid may be reduced gradually. (मोंटेलुकास्ट लेबल, चेतावनियां और सावधानियां)

Although ASMANEX HFA may improve control of asthma symptoms during these episodes, in recommended doses it supplies less than normal physiological amounts of corticosteroid systemically and does NOT provide the mineralocorticoid activity necessary for coping with these emergencies. (मोमेटासोन लेबल, चेतावनियां और सावधानियां)

Systemic/Inhaled/ Nasal/Ophthalmic Corticosteroids: e.g., betamethasone budesonide ciclesonide dexamethasone fluticasone methylprednisolone mometasone prednisone triamcinolone ↑ glucocorticoids Coadministration with corticosteroids whose exposures are significantly increased by strong CYP3A inhibitors can increase the risk for Cushing’s syndrome and adrenal suppression.Alternative… (रिटोनाविर लेबल, दवाओं के इंटरैक्शन)

…Haloperidol Barbiturates Phenobarbital Benzodiazepines Diazepam Beta-Blockers Propranolol Calcium Channel Blockers Diltiazem, nifedipine, verapamil Cardiac Glycoside Preparations Digoxin Corticosteroids Prednisone Fibrates Clofibrate Oral Hypoglycemics Sulfonylureas (e.g., glyburide, glipizide) Hormonal Contraceptives/Progestins Ethinyl estradiol, levonorgestrel Immunosuppressants… (रिफापेंटिन लेबल, दवाओं के इंटरैक्शन)

Barbiturates, phenytoin, or rifampin —increased metabolic clearance of fludrocortisone acetate because of the induction of hepatic enzymes. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Oral anticoagulants — decreased prothrombin time response. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

…the jaw include invasive dental procedures (for example, tooth extraction, dental implants, boney surgery), diagnosis of cancer, concomitant therapies (for example, chemotherapy, corticosteroids, angiogenesis inhibitors), poor oral hygiene, and co-morbid disorders (for example, periodontal and/or other pre-existing dental disease, anemia, coagulopathy, infection,… (रिसेड्रोनेट लेबल, चेतावनियां और सावधानियां)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Monitor serum potassium levels; use potassium supplements if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Therefore, for patients receiving both neuromuscular blocking agents (including Rocuronium Bromide Injection) and corticosteroids, the period of use of the neuromuscular blocking agent should be limited as much as possible and only used in the setting where in the opinion of the prescribing physician, the specific advantages of the drug outweigh the risk. (रोक्यूरोनियम लेबल, चेतावनियां और सावधानियां)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Acute Adrenal Crisis in Patients with Concomitant Adrenal Insufficiency Thyroid hormone increases metabolic clearance of glucocorticoids. (लियोथायरोनिन लेबल, चेतावनियां और सावधानियां)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Corticosteroids (systemic): cortisone/hydrocortisone dexamethasone ↑ corticosteroids (systemic) Concomitant administration with systemic corticosteroids whose exposures are significantly increased by CYP3A inhibitors can increase the risk for Cushing's syndrome and adrenal suppression. (लेनाकैपाविर लेबल, दवाओं के इंटरैक्शन)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (लेवॉर्फेनॉल लेबल, चेतावनियां)

Failure to do so may precipitate an acute adrenal crisis when thyroid hormone therapy is initiated, due to increased metabolic clearance of glucocorticoids by thyroid hormone. (लेवोथायरोक्सिन लेबल, चेतावनियां और सावधानियां)

The therapy of myxedema coma requires simultaneous administration of glucocorticoids (See DOSAGE AND ADMINISTRATION). (लेवोथायरोक्सिन और लियोथायरोनिन लेबल, सावधानियां)

Estrogen —increased levels of corticosteroid-binding globulin thereby increasing the bound (inactive) fraction; this effect is at least balanced by decreased metabolism of corticosteroids. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

The risk of developing fluoroquinolone-associated tendinitis and tendon rupture is increased in patients usually over 60 years of age, in those taking corticosteroid drugs, and in patients with kidney, heart or lung transplants. (लेवोफ्लॉक्सासिन लेबल, चेतावनियां और सावधानियां)

If the patient needs more doses of XOPENEX HFA than usual, this may be a marker of destabilization of asthma and requires reevaluation of the patient and treatment regimen, giving special consideration to the possible need for anti-inflammatory treatment, e.g., corticosteroids. (लेवोसैल्बुटामोल लेबल, चेतावनियां और सावधानियां)

…Nasal/Ophthalmic Corticosteroids: e.g., betamethasone budesonide ciclesonide dexamethasone fluticasone methylprednisolone mometasone prednisone triamcinolone ↓ lopinavir ↑ glucocorticoids Coadministration with oral dexamethasone or other systemic corticosteroids that induce CYP3A may result in loss of therapeutic effect and development of resistance to lopinavir. (लोपिनाविर और रिटोनाविर लेबल, दवाओं के इंटरैक्शन)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Oral anticoagulants — decreased prothrombin time response. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Oral Contraceptive Steroids Administration of a single-dose of ethinyloestradiol (50 mcg)/levonorgestrel (250 mcg) to 6 women on valproate (200 mg BID) therapy for 2 months did not reveal any pharmacokinetic interaction. (वैल्प्रोइक एसिड लेबल, दवाओं के इंटरैक्शन)

• Adrenal Dysfunction : Carefully monitor patients receiving voriconazole and corticosteroids (via all routes of administration) for adrenal dysfunction both during and after voriconazole treatment. (वोरिकोनाज़ोल लेबल, चेतावनियां और सावधानियां)

The neuromuscular blocking effect of succinylcholine may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase [see Warnings and Precautions (5.9) ]. (सक्सिनिलकोलिन लेबल, दवाओं के इंटरैक्शन)

Rarely salicylate toxicity may occur in patients who discontinue steroids after concurrent high-dose aspirin therapy. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

These reactions include reversible corneal toxicity, and hemorrhagic conjunctivitis, which may be prevented or diminished by prophylaxis with a local corticosteroid eye drop; cerebral and cerebellar dysfunction, including personality changes, somnolence and coma, usually reversible; severe gastrointestinal ulceration, including pneumatosis cystoides intestinalis… (साइटाराबिन लेबल, चेतावनियां)

Rarely salicylate toxicity may occur in patients who discontinue steroids after concurrent high-dose aspirin therapy. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Although ALVESCO may provide control of asthma symptoms during these episodes, in recommended doses it supplies less than normal physiological amounts of corticosteroid systemically and does NOT provide the mineralocorticoid activity that is necessary for coping with these emergencies. (सिक्लेसोनाइड लेबल, चेतावनियां और सावधानियां)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

The risk of developing fluoroquinolone-associated tendinitis and tendon rupture is increased in patients over 60 years of age, in patients taking corticosteroid drugs, and in patients with kidney, heart or lung transplants. (सिप्रोफ्लॉक्सासिन लेबल, चेतावनियां और सावधानियां)

Other factors that increase the risk for gastrointestinal bleeding in patients treated with NSAIDs include longer duration of NSAID therapy; concomitant use of oral corticosteroids, aspirin, anticoagulants, or selective serotonin reuptake inhibitors (SSRIs); smoking; use of alcohol; older age; and poor general health status. (सुमाट्रिप्टान और नेप्रोक्सेन लेबल, चेतावनियां और सावधानियां)

Other factors that increase the risk for GI bleeding in patients treated with NSAIDs include concomitant use of oral corticosteroids or anticoagulants, longer duration of NSAID therapy, smoking, use of alcohol, older age, and poor general health status. (सुलिंडैक लेबल, चेतावनियां)

High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (सेफॉक्सिटिन लेबल, चेतावनियां और सावधानियां)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Other factors that increase the risk of GI bleeding in patients treated with NSAIDs include longer duration of NSAID therapy; concomitant use of oral corticosteroids, antiplatelet drugs (such as aspirin), anticoagulants; or selective serotonin reuptake inhibitors (SSRIs); smoking; use of alcohol; older age; and poor general health status. (सेलेकॉक्सिब लेबल, चेतावनियां और सावधानियां)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Monitor for symptoms of hyperglycemia; adjust dosage of antidiabetic drug upward if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

If the patient needs more doses of Albuterol Sulfate HFA than usual, this may be a marker of destabilization of asthma and requires reevaluation of the patient and treatment regimen, giving special consideration to the possible need for anti-inflammatory treatment, e.g., corticosteroids. (सैल्बुटामोल लेबल, चेतावनियां और सावधानियां)

Monitor serum potassium levels; use potassium supplements if necessary. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Use of corticosteroids may cause a protein catabolic state and, thereby, potentially increase plasma ammonia levels in patients with impaired ability to form urea. (सोडियम फिनाइलएसीटेट और सोडियम बेंज़ोएट लेबल, दवाओं के इंटरैक्शन)

Valproic Acid, Haloperidol, or Corticosteroids : May increase plasma ammonia level; monitor ammonia levels closely. (सोडियम फिनाइलब्यूटिरेट लेबल, दवाओं के इंटरैक्शन)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Long-term treatment with steroids may be necessary (see PRECAUTIONS, Laboratory Tests ). (हाइड्रालाज़िन लेबल, चेतावनियां)

Average and large doses of hydrocortisone or cortisone can cause elevation of blood pressure, salt and water retention, and increased excretion of potassium. (फ्लुड्रोकॉर्टिसोन लेबल, चेतावनियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (हाइड्रोकोडोन लेबल, चेतावनियां और सावधानियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (हाइड्रोकोडोन और आइबुप्रोफेन लेबल, चेतावनियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (हाइड्रोकोडोन और क्लोरफेनिरामिन लेबल, चेतावनियां और सावधानियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (हाइड्रोकोडोन और पैरासिटामोल लेबल, चेतावनियां)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (हाइड्रोकोडोन और होमाट्रोपिन लेबल, चेतावनियां और सावधानियां)

Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. (हाइड्रोमॉर्फोन लेबल, चेतावनियां और सावधानियां)

Oral anticoagulants — decreased prothrombin time response. (फ्लुड्रोकॉर्टिसोन लेबल, दवाओं के इंटरैक्शन)

Caution is advised when haloperidol decanoate is used in combination with drugs known to cause electrolyte imbalance (e.g., diuretics or corticosteroids) because hypokalemia, hypomagnesemia, and hypocalcemia are risk factors for QT prolongation. (हेलोपेरिडोल लेबल, दवाओं के इंटरैक्शन)

Use of more than one corticosteroid-containing product at the same time may increase the total systemic exposure to topical corticosteroids. (हेलोबेटासोल लेबल, चेतावनियां और सावधानियां)

ATROVENT HFA has been used concomitantly with other drugs, including sympathomimetic bronchodilators, methylxanthines, oral and inhaled steroids commonly used in the treatment of COPD. (इप्राट्रोपियम लेबल, दवाओं के इंटरैक्शन)

Appropriate antihistamines and/or corticosteroids may improve the tolerability and hasten the resolution of rash. (एफाविरेंज़ लेबल, चेतावनियां और सावधानियां)

Appropriate antihistamines and/or corticosteroids may improve the tolerability and hasten the resolution of rash. (एफाविरेंज़, लैमिवुडिन और टेनोफोविर लेबल, चेतावनियां और सावधानियां)

Most patients with hypersensitivity pneumonitis discontinued treatment with ARIKAYCE and received treatment with corticosteroids [see Adverse Reactions (6.1) ] . (एमिकासिन लेबल, चेतावनियां और सावधानियां)

Antithyroid drugs, β-adrenergic blockers, temporary corticosteroid therapy may be necessary to treat the symptoms of hyperthyroidism. (एमियोडेरोन लेबल, चेतावनियां और सावधानियां)

OXYGEN, INTRAVENOUS STEROIDS, AND AIRWAY MANAGEMENT, INCLUDING INTUBATION, SHOULD ALSO BE ADMINISTERED AS INDICATED. (एम्पीसिलिन लेबल, चेतावनियां)

Drug/Laboratory Test Interactions Amphetamines can cause a significant elevation in plasma corticosteroid levels. (एम्फेटामाइन लेबल, दवाओं के इंटरैक्शन)

Interference with Laboratory Tests Amphetamines can cause a significant elevation in plasma corticosteroid levels. (एम्फेटामाइन और डेक्सट्रोएम्फेटामाइन लेबल, दवाओं के इंटरैक्शन)

If signs of hypersensitivity occur, e.g. anaphylactoid reaction or angioedema develops, discontinue the Activase infusion and promptly institute appropriate therapy (e.g., antihistamines, intravenous corticosteroids, epinephrine). (एल्टेप्लेज़ लेबल, चेतावनियां और सावधानियां)

If an allergic reaction occurs, the drug should be discontinued and the patient should receive supportive treatment, e.g. , artificial maintenance of ventilation, pressor amines, antihistamines, and corticosteroids. (ऑक्सासिलिन लेबल, चेतावनियां)

Most patients improved promptly with discontinuation of fluoxetine and/or adjunctive treatment with antihistamines or steroids, and all patients experiencing these reactions were reported to recover completely. (ओलैंज़ापिन और फ्लुओक्सेटिन लेबल, चेतावनियां और सावधानियां)

…clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, dihydropyridine calcium channel blockers (e.g., felodipine), doxycycline, ethosuximide, everolimus, felbamate, glucocorticoids, haloperidol, imatinib, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, methsuxamide, mianserin, midazolam, mirtazapine, nefazodone, olanzapine, oral… (कार्बामाज़ेपिन लेबल, दवाओं के इंटरैक्शन)

Some subjects in the EPIDIOLEX clinical trials had pruritus, erythema, and angioedema requiring treatment, including corticosteroids and antihistamines. (कैनाबिडियोल (प्रिस्क्रिप्शन दवा) लेबल, चेतावनियां और सावधानियां)

Corticosteroids A relationship of functional antagonism exists between vitamin D analogues, which promote calcium absorption, and corticosteroids, which inhibit calcium absorption. (कैल्सिट्रिओल लेबल, दवाओं के इंटरैक्शन)

The recovery of the adrenal gland may take from days to months so patients should be protected from the stress (e.g., trauma or surgery) by the use of corticosteroids during the period of stress. (कॉर्टिकोट्रोपिन लेबल, चेतावनियां और सावधानियां)

The use of prophylactic steroids (e.g., 100 mg/m 2 hydrocortisone on Days 1 through 3) may be of benefit in preventing signs or symptoms of SIRS or capillary leak syndrome. (क्लोफाराबिन लेबल, चेतावनियां और सावधानियां)

Elevated urinary steroid levels, varying degrees of electrolyte imbalance, hypovolemia, hemoconcentration, and hypoproteinemia may occur. (क्लोमीफीन लेबल, चेतावनियां)

Drug/Laboratory Interactions Quinine may produce an elevated value for urinary 17-ketogenic steroids when the Zimmerman method is used. (क्विनीन लेबल, दवाओं के इंटरैक्शन)

In the reported cases NME resolved with discontinuation of the glucagon, and treatment with corticosteroids was not effective. (ग्लूकागॉन लेबल, चेतावनियां और सावधानियां)

Most patients improved promptly with adjunctive treatment with antihistamines or steroids and/or upon discontinuation of ziprasidone, and all patients experiencing these reactions were reported to recover completely. (ज़िप्रासिडोन लेबल, चेतावनियां और सावधानियां)

If symptoms of hypersensitivity occur, initiate appropriate therapy (e.g., antihistamines, corticosteroids, epinephrine). (टेनेक्टेप्लेज़ लेबल, चेतावनियां और सावधानियां)

In clinical studies, patients receiving TOBI Podhaler continued to take dornase alfa, bronchodilators, inhaled corticosteroids, and macrolides. (टोब्रामाइसिन लेबल, दवाओं के इंटरैक्शन)

Fluid retention events were typically managed by supportive care measures that may include diuretics or short courses of steroids. (डासाटिनिब लेबल, चेतावनियां और सावधानियां)

Drug/Laboratory Test Interactions Amphetamines can cause a significant elevation in plasma corticosteroid levels. (डेक्सट्रोएम्फेटामाइन लेबल, दवाओं के इंटरैक्शन)

These would include diuretics, laxatives and supraphysiological use of steroid hormones with mineralocorticoid potential. (ड्रोपेरिडोल लेबल, दवाओं के इंटरैक्शन)

Both cases required hospitalization, and resolved after treatment with antibiotics and corticosteroids. (नाल्ट्रेक्सोन लेबल, चेतावनियां और सावधानियां)

Oxygen, intravenous steroids, and airway management, including intubation, should also be administered as indicated. (पेनिसिलिन G लेबल, चेतावनियां)

OXYGEN, INTRAVENOUS STEROIDS, AND AIRWAY MANAGEMENT, INCLUDING INTUBATION, SHOULD ALSO BE ADMINISTERED AS INDICATED. (पेनिसिलिन V लेबल, चेतावनियां)

Since mineralocorticoid secretion may be impaired, salt and/or a mineralocorticoid should be administered concurrently. (प्रेडनिसोन लेबल, चेतावनियां और सावधानियां)

Since mineralocorticoid secretion may be impaired, salt and/or a mineralocorticoid should be administered concurrently. (प्रेडनिसोलोन लेबल, चेतावनियां और सावधानियां)

In some cases, vasculitis resolved/improved with drug discontinuation; however, more severe cases required treatment with additional measures including corticosteroids, immunosuppressant therapy, and plasmapheresis. (प्रोपाइलथायोयूरेसिल लेबल, चेतावनियां)

Most patients improved promptly with discontinuation of fluoxetine and/or adjunctive treatment with antihistamines or steroids, and all patients experiencing these reactions were reported to recover completely. (फ्लुओक्सेटिन लेबल, चेतावनियां और सावधानियां)

Steroids may or may not be effective in controlling these hemolytic episodes. (फ्लुडाराबिन लेबल, चेतावनियां और सावधानियां)

The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (बुसल्फान लेबल, चेतावनियां)

Tendon rupture may occur more frequently in patients over 60 years of age, in those taking corticosteroid or fluoroquinolone drugs, in patients with renal failure, and in patients with previous tendon disorders. (बेम्पेडोइक एसिड लेबल, चेतावनियां और सावधानियां)

Discontinue in patients who develop a severe infusion-related reaction and administer appropriate medical therapy (e.g., epinephrine, corticosteroids, intravenous antihistamines, bronchodilators and/or oxygen). (बेवासिज़ुमैब लेबल, चेतावनियां और सावधानियां)

Following concurrent administration of mitoxantrone injection with corticosteroids, no evidence of drug interactions has been observed. (माइटोक्सैंट्रोन लेबल, दवाओं के इंटरैक्शन)

Drug/Laboratory Test Interactions Amphetamines can cause a significant elevation in plasma corticosteroid levels. (मेथएम्फेटामाइन लेबल, दवाओं के इंटरैक्शन)

In some cases, vasculitis resolved/improved with drug discontinuation; however, more severe cases required treatment with additional measures including corticosteroids, immunosuppressant therapy, and plasmapheresis. (मेथिमाज़ोल लेबल, चेतावनियां)

The infusion should be terminated immediately, followed by the administration of volume expanders, pressor agents, corticosteroids, or antihistamines at the discretion of the physician. (मेलफलान लेबल, चेतावनियां)

Other Concomitant Medications EVISTA can be concomitantly administered with ampicillin, amoxicillin, antacids, corticosteroids, and digoxin [see Clinical Pharmacology ( 12.3 )] . (रैलोक्सीफेन लेबल, दवाओं के इंटरैक्शन)

Patients with Grade 1 and 2 TFR may also be treated with corticosteroids, non-steroidal anti-inflammatory drugs (NSAIDs) and/or narcotic analgesics for management of TFR symptoms. (लेनालिडोमाइड लेबल, चेतावनियां और सावधानियां)

प्रेडनिसोन जैसे कॉर्टिकोस्टेरॉइड कैल्शियम का अवशोषण कम करते हैं और विटामिन D के मेटाबॉलिज़्म को बिगाड़ते हैं, जिससे हड्डियों के क्षय में योगदान होता है। (NIH Office of Dietary Supplements, Vitamin D)

SERIOUS ACUTE HYPERSENSITIVITY REACTIONS MAY REQUIRE TREATMENT WITH EPINEPHRINE AND OTHER EMERGENCY MEASURES, INCLUDING OXYGEN, INTRAVENOUS FLUIDS, INTRAVENOUS ANTIHISTAMINES, CORTICOSTEROIDS, PRESSOR AMINES, AND AIRWAY MANAGEMENT, AS CLINICALLY INDICATED. (सेफडिनिर लेबल, चेतावनियां)

SERIOUS ACUTE HYPERSENSITIVITY REACTIONS MAY REQUIRE TREATMENT WITH EPINEPHRINE AND OTHER EMERGENCY MEASURES, INCLUDING OXYGEN, INTRAVENOUS FLUIDS, INTRAVENOUS ANTIHISTAMINES, CORTICOSTEROIDS, PRESSOR AMINES, AND AIRWAY MANAGEMENT, AS CLINICALLY INDICATED. (सेफप्रोज़िल लेबल, चेतावनियां)

SERIOUS ACUTE HYPERSENSITIVITY REACTIONS MAY REQUIRE TREATMENT WITH EPINEPHRINE AND OTHER EMERGENCY MEASURES, INCLUDING OXYGEN, INTRAVENOUS FLUIDS, INTRAVENOUS ANTIHISTAMINES, CORTICOSTEROIDS, PRESSOR AMINES, AND AIRWAY MANAGEMENT, AS CLINICALLY INDICATED. (सेफाक्लोर लेबल, चेतावनियां)

SERIOUS ACUTE HYPERSENSITIVITY REACTIONS MAY REQUIRE TREATMENT WITH EPINEPHRINE AND OTHER EMERGENCY MEASURES, INCLUDING OXYGEN, INTRAVENOUS FLUIDS, INTRAVENOUS ANTIHISTAMINES, CORTICOSTEROIDS, PRESSOR AMINES, AND AIRWAY MANAGEMENT, AS CLINICALLY INDICATED. (सेफाड्रोक्सिल लेबल, चेतावनियां और सावधानियां)

SERIOUS ACUTE HYPERSENSITIVITY REACTIONS MAY REQUIRE TREATMENT WITH EPINEPHRINE AND OTHER EMERGENCY MEASURES, INCLUDING OXYGEN, INTRAVENOUS FLUIDS, INTRAVENOUS ANTIHISTAMINES, CORTICOSTEROIDS, PRESSOR AMINES, AND AIRWAY MANAGEMENT, AS CLINICALLY INDICATED. (सेफोटेटन लेबल, चेतावनियां)

SERIOUS ACUTE HYPERSENSITIVITY REACTIONS MAY REQUIRE TREATMENT WITH EPINEPHRINE AND OTHER EMERGENCY MEASURES, INCLUDING OXYGEN, IV FLUIDS, IV ANTIHISTAMINES, CORTICOSTEROIDS, PRESSOR AMINES, AND AIRWAY MANAGEMENT, AS CLINICALLY INDICATED. (सेफ्टाज़िडिम लेबल, चेतावनियां)

Serious acute hypersensitivity reactions may require treatment with epinephrine and other emergency measures including oxygen, corticosteroids, intravenous fluids, intravenous antihistamines, pressor amines, and airway management, as clinically indicated. (सेफ्ट्रिएक्सोन लेबल, चेतावनियां और सावधानियां)